5 Mar 2018 - Robert Passier appointed ambassador of the Netherlands Heart Institute
Robert Passier, professor at the University of Twente (UT) and the Leiden University Medical Center (LUMC), has been appointed as an ambassador of the Netherlands Heart Institute (NL-HI). In this capacity Passier will forge links between technical universities and university medical centres in the field of biomedical technology and applications for cardiovascular disease. The aim is to make new technologies more widely applicable and more quickly accessible to patients.
27 Feb 2018 - With Health EU, everyone will have an avatar to manage their health
In the future, will people have virtual twins to help monitor their health? That is what Health EU is proposing. This major project, led by a consortium headed by EPFL, is in the running to be a European Union FET Flagship project. If successful, it will receive €1 billion in financing over ten years.
15 Feb 2018 - Male and female brain rhythms show differences
The electric brain signals, measured by using EEG, of males and females show differences. The difference can’t be detected by visual inspection, not even by the trained eye of a neurologist. A ‘deep learning’ computer is able to find it. Researchers of the University of Twente, the University of Zürich and Brainclinics research institute in Nijmegen, publish these results in Scientific Reports of 15 February.
12 Feb 2018 - ZonMw TOP Grant for heart cell differentiation
How do cells grow out to be heart cells? And how do these cells ripe to being fully functional heart cells? Researchers University of Twente and Radboud University hope to answer these questions. ZonMw awards the research of molecular regulation mechanisms from human heart cells a TOP grant of 675.000 euros.
1 Feb 2018 - Developing a urine test for various types of cancer
Detecting cancer of various types, in a very early stage and using a simple urine sample. That is the ambition of the new startup company NanoMed Diagnostics. Years of research, by scientists of the University of Twente and the VU University Medical Center Amsterdam (VUmc) led to a new approach using nanotechnology. Together with the new company, the researchers will further develop this towards a test that is ready for clinical use.